Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(6 sites)
China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Cancer Center of Guangzhou Medical University, Guangzhou, Guangdong Yuebei People's Hospital, Shaoguan, Guangdong Zhongshan People's Hospital, Zhongshan, Guangdong The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Wuzhou Red Cross Hospital, Wuzhou, Guangxi Age range
18 Years – 70 Years
Last updated September 2020